Suppr超能文献

作为(印度人参)草药产品所观察到的肝脏毒性的潜在原因,睡茄内酯对DNA的损伤。

DNA damage by Withanone as a potential cause of liver toxicity observed for herbal products of (Ashwagandha).

作者信息

Siddiqui Shazia, Ahmed Nabeel, Goswami Mausumi, Chakrabarty Anindita, Chowdhury Goutam

机构信息

Department of Life Sciences, Shiv Nadar University, Greater Noida, UP 201314, India.

Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology, Vellore, TN 632014, India.

出版信息

Curr Res Toxicol. 2021 Feb 16;2:72-81. doi: 10.1016/j.crtox.2021.02.002. eCollection 2021.

Abstract

commonly known as Ashwagandha, is a medicinal plant used for thousands of years for various remedies. Extracts of Ashwagandha contain more than 200 metabolites, with withanone (win) being one of the major ones responsible for many of its medicinal properties. Recently, several cases of liver toxicity resulting from commercially available Ashwagandha products have been reported The first report of Ashwagandha-related liver damage was from Japan, which was quickly resolved after drug-withdrawal. Later, similar cases of liver toxicity due to Ashwagandha consumption were reported from the USA and Iceland. Towards understanding the liver toxicity of Ashwagandha extracts, we studied win, a representative withanolide having toxicophores or structural alerts that are commonly associated with adverse drug reactions. We found that win can form non-labile adducts with the nucleosides dG, dA, and dC. Using various biochemical assays, we showed that win forms adducts in DNA and interfere with its biological property. Win also forms adducts with amines and this process is reversible. Based on the data presented here we concluded that win is detoxified by GSH but under limiting GSH levels it can cause DNA damage. The work presented here provides a potential mechanism for the reported Ashwagandha-mediated liver damage.

摘要

通常被称为印度人参,是一种药用植物,数千年来一直用于各种治疗方法。印度人参提取物含有200多种代谢物,其中Withanone(WIN)是其许多药用特性的主要负责成分之一。最近,有报道称市售印度人参产品导致了几例肝毒性病例。第一例与印度人参相关的肝损伤报告来自日本,停药后很快得到解决。后来,美国和冰岛也报告了因食用印度人参而导致肝毒性的类似病例。为了了解印度人参提取物的肝毒性,我们研究了WIN,一种具有毒基团或结构警示的代表性维A醇内酯,这些通常与药物不良反应有关。我们发现WIN可以与核苷dG、dA和dC形成不稳定加合物。通过各种生化分析,我们表明WIN在DNA中形成加合物并干扰其生物学特性。WIN还与胺形成加合物,并且这个过程是可逆的。基于此处提供的数据,我们得出结论,WIN通过谷胱甘肽解毒,但在谷胱甘肽水平有限的情况下,它会导致DNA损伤。此处介绍的工作为报道的印度人参介导的肝损伤提供了一种潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcc4/8320610/f931ee0c5efb/ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验